Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3280](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3280) → OEH — Joint Biological Agent Identification And Diagnostic System (Jbaids) Tularemia Detection Kit

# OEH · Joint Biological Agent Identification And Diagnostic System (Jbaids) Tularemia Detection Kit

_Microbiology · 21 CFR 866.3280 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OEH

## Overview

- **Product Code:** OEH
- **Device Name:** Joint Biological Agent Identification And Diagnostic System (Jbaids) Tularemia Detection Kit
- **Regulation:** [21 CFR 866.3280](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3280)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Francisella tularensis serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to Francisella tularensis in serum or to identify Francisella tularensis in cultured isolates derived from clinical specimens. Additionally, some of these reagents consist of antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify Francisella tularensis directly from clinical specimens. The identification aids in the diagnosis of tularemia caused by Francisella tularensis and provides epidemiological information on this disease. Tularemia is a desease principally of rodents, but may be transmitted to humans through handling of infected animals, animal products, or by the bites of fleas and ticks. The disease takes on several forms depending upon the site of infection, such as skin lesions, lymph node enlargements, or pulmonary infection.

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K131936](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OEH/K131936.md) | JBAIDS TULAREMIA DETECTION KIT | Biofire Diagnostics, Inc. | Jul 31, 2013 | SESE |
| [K072547](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OEH/K072547.md) | JBAIDS TULAREMIA DETECTION KIT, MODEL JRPD-ASY-0124 | Idaho Technology, Inc. | Dec 19, 2007 | SESE |

## Top Applicants

- Biofire Diagnostics, Inc. — 1 clearance
- Idaho Technology, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OEH](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OEH)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com